| (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide |
N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺 |
273404-37-8 |
| WNK463 |
N-(叔丁基)-1-(1-(5-(5-(三氟甲基)-1,3,4-恶二唑-2-基)吡啶-2-基)哌啶-4-基)-1H-咪唑-5-甲酰胺 |
2012607-27-9 |
| CP-456773 sodium |
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 |
256373-96-3 |
| ADH 1 |
N-钙粘蛋白拮抗剂 |
229971-81-7 |
| IXABEPILONE |
伊沙匹隆 |
219989-84-1 |
| PD184352 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
212631-79-3 |
| SRPK inhibitor |
SRPKINHIBITOR |
218156-96-8 |
| Entinostat |
恩替诺特 |
209783-80-2 |
| Sitaxentan sodium |
西他生坦钠 |
210421-74-2 |
| WBYNZQXAAWPAGR-UHFFFAOYSA-N |
CS-2866 |
1637300-25-4 |
| ReModelin hydrobroMide |
REMODELIN |
1622921-15-6 |
| ISRIB (trans-isoMer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
| SGC0946 |
SGC0946 |
1561178-17-3 |
| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
| Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| Verdinexor (KPT-335) |
Verdinexor (KPT-335) |
1392136-43-4 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
QQ
微信
